The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD), is a comprehensive training program in clinical trials for Alzheimer’s disease and related dementias (ADRD). The course is directed by UCI MIND faculty member Joshua Grill and USC faculty member Dr. Rema Raman. Though in its third year, 2022 was the first time this innovative course could could be held in person and it was a resounding success. Throughout this past week, trainees from around the country, along with many of the nation’s best AD clinical trial investigators, stayed in La Jolla’s Estancia Hotel for an immersive, interactive, and comprehensive program.
More than 100 investigators with diverse backgrounds, interests, and roles in clinical trials have now participated in IMPACT-AD, which is funded by grants from the National Institute on Aging and the Alzheimer’s Association. IMPACT-AD is achieving its mission to train and diversify the next generation of AD/ADRD clinical trialists.
